Gyon Technologies Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Gyon Technologies Capital Management’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$388K	Buy
2022 Q1	–	Sell
2021 Q4	$205K	Buy
2021 Q3	$478K	Buy
2021 Q2	–	Sell
2021 Q1	$2.02M	Buy
2020 Q4	$1.4M	Buy